3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-, (3S,4aS,8aS)-, methanesulfonate (1:1)

CAS: 159989-65-8

Rif. AN-AG001RK1

Informazioni sul prodotto

• Nome: 3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-, (3S,4aS,8aS)-, methanesulfonate (1:1)
• Sinonimi: [u'AG 1343', u'AG-1343', u'AG1343', u'Mesylate, Nelfinavir', u'Monomethane Sulfonate, Nelfinavir', u'Nelfinavir', u'Nelfinavir Mesylate', u'Nelfinavir Monomethane Sulfonate', u'Sulfonate, Nelfinavir Monomethane', u'Viracept', u'Nelfinavir mesylate', u'159989-65-8', u'Viracept', u'Nelfinavir mesilate', u'Nelfinavir mesylate hydrate', u'Nelfin', u'Nelfinavir Mesylate [USAN]', u'UNII-98D603VP8V', u'HSDB 7159', u'C32H45N3O4S.CH4O3S', u'Nelfinavir Methanesulfonate', u'AG-1343', u'Nelfinavir (Mesylate)', u'CHEBI:7497', u'AG1343', u'Nelfinavir methanesulfonate hydrate', u'98D603VP8V', u'AG 1343', u'MFCD00931436', u'Viracept (TN)', u'NFV', u'DSSTox_CID_10777', u'DSSTox_RID_79093', u'DSSTox_GSID_33736', u'CHEMBL1205', u'(3S,4aS,8aS)-N-tert-Butyl-2-((2R,3R)-3-(3,2-cresotamido)-2-hydroxy-4-(phenylthio)butyl)decahydro-3-isoquinolinecarboxamide monomethanesulfonate (salt)', u'3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-((2R,3R)-2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-, (3S,4aS,8aS)-, monomethanesulfonate (salt)', u'3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-(2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-, (3S-(2(2,S*,3S*),3-alpha,4a-beta,8a-beta))-, monomethanesulfonate (salt)', u'3S,4aS,8aS)-N-(1,1-Dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-3-isoquinolinecarboxamide methanesulfonate', u'SMR000469186', u'CAS-159989-65-8', u'NSC722664', u'NCGC00090782-03', u'Nelfinivir', u'nelfinavir-mesylate', u'AG 1343 Mesylate', u'Nelfinavir mesilate (JAN)', u'AZT/3TC/NLFR combination', u'SCHEMBL40942', u'(3S,4aS,8aS)-N-(1,1-Dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-3-isoquinolinecarboxamide', u'MLS001055355', u'MLS001401378', u'MLS006010141', u'AC1L20J3', u'ARV-SR0121', u'DTXSID2033736', u'CTK8E9065', u'Nelfinavir mesylate (USAN/INN)', u'SYN3022', u'C33H49N3O7S2', u'NQHXCOAXSHGTIA-SKXNDZRYSA-N', u'HMS2051N05', u'HMS2090L17', u'HMS2233M20', u'HMS3261P12', u'HMS3715B04', u'Tox21_111021', u'Tox21_200921', u'Tox21_500635', u's4282', u'AKOS015963185', u'Tox21_111021_1', u'AG-1346', u'CCG-100925', u'KS-1089', u'NC00175', u'NSC-722664', u'NCGC00090782-01', u'NCGC00090782-06', u'NCGC00258475-01', u'NCGC00261320-01', u'AC-20033', u'AN-31041', u'CPD000469186', u'LS-85416', u'SAM001246655', u'SC-79735', u'LY-312857', u'RT-014683', u'N0986', u'Nelfinavir mesylate hydrate, >=98% (HPLC)', u'SW197555-2', u'C08091', u'D00899', u'W-5226', u'989N658', u'J-009662', u'(3S, 4aS, 8aS)-2-[(2R, 3R)-2-hydroxy-3-(3-hydroxy-2-methylbenzoylamino)-4-phenylthiobutyl]decahydroiso-quinoline-3-carboxylic acid t-butylamide methanesulfonate', u'(3S, 4aS, 8aS)-2-[(2R, 3R)-2-hydroxy-3-(3-hydroxy-2-methylbenzoylamino)-4-phenylthiobutyl]decahydroisoquinoline-3-carboxylic acid t-butylamide methanesulfonate', u'(3S,4aS,8aS)-2-[(2R,3R)-2-hydroxy-3-(3-hydroxy-2-methylbenzoylamino)-4-phenylthiobutyl]decahydroisoquinoline-3-carboxylic acid t-butylamide methanesulfonate'], (3S,4As,8As)-N-(1,1-Dimethylethyl)Decahydro-2-[(2R,3R)-2-Hydroxy-3-[(3-Hydroxy-2-Methylbenzoyl)Amino]-4-(Phenylthio)Butyl]-3-Isoquinolinecarboxamide Mesylate, (3S,4aS,8aS)-N-(1,1-Dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-3-isoquinolinecarboxamide, 3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-, (3S,4aS,8aS)-, monomethanesulfonate (salt), 3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-[2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-, [3S-[2(2S*,3S*),3α,4aβ,8aβ]]-, monomethanesulfonate (salt), 8A-Beta))-A-Betmonomethanesulfonate(Salt), Ag-1343, Droxy-2-Methylbenzoyl)Amino)-4-(Phenylthio)Butyl)-,(3S-(2(2,S*,3S*),3-Alpha,4, Nelfin, Nelfinavir mesilate, Nelfinavir1, Nelfinivir, Viracept
• CAS: 159989-65-8
• Marchio: Indagoo

Proprietà chimiche

• Peso molecolare: 663.8881
• Formula: C₃₃H₄₉N₃O₇S₂
• Purezza: 98%
• Colore/Forma: Solid
• InChI: InChI=1S/C32H45N3O4S.CH4O3S/c1-21-25(15-10-16-28(21)36)30(38)33-26(20-40-24-13-6-5-7-14-24)29(37)19-35-18-23-12-9-8-11-22(23)17-27(35)31(39)34-32(2,3)4;1-5(2,3)4/h5-7,10,13-16,22-23,26-27,29,36-37H,8-9,11-12,17-20H2,1-4H3,(H,33,38)(H,34,39);1H3,(H,2,3,4)/t22-,23+,26-,27-,29+;/m0./s1
• InChI key: NQHXCOAXSHGTIA-SKXNDZRYSA-N